"People who are obese may be more susceptible to environmental food cues than their lean counterparts due to differences in brain chemistry that make eating more habitual and less rewarding, according to a National Institutes of Health study pu"...
Phendimetrazine tartrate tablets are indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (see CLINICAL PHARMACOLOGY) should be measured against possible risk factors inherent in their use such as those described below.
DOSAGE AND ADMINISTRATION
Each single-scored, yellow, round tablet contains 35 mg phendimetrazine tartrate. Tablets are supplied in bottles of 100 (NDC 46672-138-10) and in bottles of 1000 (NDC 46672-138-11).
Each single-scored, blue, unimprinted round tablet contains 35 mg phendimetrazine tartrate. Tablets are supplied in bottles of 100 (NDC 46672-057-10) and in bottles of 1000 (NDC 46672-057-11).
Store at controlled room temperature 15°-30°C (59°-86°F).
Dispense in tight containers with child-resistant closures.
Manufactured by: Mikart, Inc., Atlanta, GA 30318. Rev. 05/96.
Last reviewed on RxList: 4/20/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Phendimetrazine Tartrate Information
Phendimetrazine Tartrate - User Reviews
Phendimetrazine Tartrate User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.